Molecular mechanisms of intensive care unit-acquired weakness
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Intensive care unit-acquired weakness (ICUAW) is an increasingly recognised and important clinical consequence of critical illness. It is associated with significant morbidity and mortality. The aetiology of this disease is not well understood. The purpose of this article is to review our understanding of the molecular pathogenesis of ICUAW in the context of current knowledge of clinical risk factors and aetiology. Key features of the disease are loss of muscle mass resulting from a shift in the dynamic balance of muscle protein synthesis and breakdown and a reduction in force-generating capacity. These alternations are secondary to neuropathy, disruption of the myofilament structure and function, a disrupted sarcoplasmic reticulum, electrical inexcitability and bioenergenetic failure. As knowledge and understanding of ICUAW grows, potential therapeutic targets will be identified, hopefully leading to multiple strategies for prevention and treatment of this important condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571
Glover, E. I., Phillips, S. M., Oates, B. R., Tang, J. E., Tarnopolsky, M. A., Selby, A., Smith, K., & Rennie, M. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160333 · Cited by 414
Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-665oc · Cited by 368
Lower limb skeletal muscle function after 6 wk of bed rest
Berg, H. E., Larsson, L., & Tesch, P. A. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.82.1.182 · Cited by 352
Cited by
Clinical review: intensive care unit acquired weakness
Hermans, G., & Van den Berghe, G. (2015) · Critical Care · doi:10.1186/s13054-015-0993-7 · Cited by 792
“These include inflammation, immobilization, the endocrine stress responses, the rapidly developing nutritional deficit, impaired microcirculation, and denervation [22, 27, 28].”
BackgroundEarly Active Mobilization during Mechanical Ventilation in the ICU
The TEAM Study Investigators and the ANZICS Clinical Trials Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2209083 · Cited by 439
Physical Therapy for the Critically Ill in the ICU: A Systematic Review and Meta-Analysis*
Kayambu, G., Boots, R., & Paratz, J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827ca637 · Cited by 438
The impact of extended bed rest on the musculoskeletal system in the critical care environment
Parry, S. M., & Puthucheary, Z. A. (2015) · Extreme Physiology & Medicine · doi:10.1186/s13728-015-0036-7 · Cited by 383
“This is postulated to trigger muscle proteolytic pathways [98, 100] and interfere with insulin signalling, leading to anabolic resistance [88], and contribute to electrophysiological inexcitability of the muscle [101, 102].”
BackgroundInfluentialGarros, R. F., Paul, R., Connolly, M., Lewis, A., Garfield, B. E., Natanek, S. A., Bloch, S., Mouly, V., Griffiths, M. J., Polkey, M. I., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0101oc · Cited by 86
Self-citation
Metadata
- Authors
- Bloch, S., Polkey, M. I., Griffiths, M., & Kemp, P.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2011-09-29
- Volume
- 39
- Issue
- 4
- Pages
- 1000-1011
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2132267762
- Cited by
- 90
- References
- 13
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular mechanisms of intensive care unit-acquired weakness. https://app.cochat.ai/papers/10.1183/09031936.00090011
- The paper
- Bloch, S., Polkey, M. I., Griffiths, M., & Kemp, P. (2012). Molecular mechanisms of intensive care unit-acquired weakness. European Respiratory Journal. https://doi.org/10.1183/09031936.00090011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.